{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:13:08Z","timestamp":1783548788625,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T00:00:00Z","timestamp":1297728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11255-010-9897-2","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T05:17:41Z","timestamp":1297660661000},"page":"541-547","source":"Crossref","is-referenced-by-count":57,"title":["Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Anton","family":"Lishmanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smrita","family":"Dorairajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngju","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Chockalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"issue":"17","key":"9897_CR1","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038\u20132047","journal-title":"JAMA"},{"issue":"5","key":"9897_CR2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 42(5):1050\u20131065","journal-title":"Hypertension"},{"key":"9897_CR3","doi-asserted-by":"crossref","unstructured":"Daly C (2007) Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK consensus conference on early chronic kidney disease. Nephrol Dial Transplant 22(Suppl 9): ix19\u2013ix25","DOI":"10.1093\/ndt\/gfm445"},{"issue":"3","key":"9897_CR4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","volume":"11","author":"N Kimata","year":"2007","unstructured":"Kimata N et al (2007) Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int 11(3):340\u2013348","journal-title":"Hemodial Int"},{"key":"9897_CR5","doi-asserted-by":"crossref","unstructured":"Marco MP et al. (2003) Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population. Kidney Int Suppl(85):S111\u2013S114","DOI":"10.1046\/j.1523-1755.63.s85.26.x"},{"issue":"3","key":"9897_CR6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW et al (2005) Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns study. Kidney Int 67(3):1179\u20131187","journal-title":"Kidney Int"},{"issue":"11","key":"9897_CR7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","volume":"73","author":"CP Kovesdy","year":"2008","unstructured":"Kovesdy CP et al (2008) Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int 73(11):1296\u20131302","journal-title":"Kidney Int"},{"issue":"11","key":"9897_CR8","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1097\/01.ASN.0000034202.91413.EB","volume":"13","author":"IH Boer De","year":"2002","unstructured":"De Boer IH et al (2002) The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. J Am Soc Nephrol 13(11):2762\u20132769","journal-title":"J Am Soc Nephrol"},{"issue":"4 Suppl 4","key":"9897_CR9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2008.11.029","volume":"53","author":"R Bhuriya","year":"2009","unstructured":"Bhuriya R et al (2009) Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the kidney early evaluation program (KEEP). Am J Kidney Dis 53(4 Suppl 4):S3\u2013S10","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"9897_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","volume":"11","author":"E Kamycheva","year":"2004","unstructured":"Kamycheva E, Sundsfjord J, Jorde R (2004) Serum parathyroid hormone levels predict coronary heart disease: the Tromso study. Eur J Cardiovasc Prev Rehabil 11(1):69\u201374","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"21","key":"9897_CR11","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstrom","year":"2009","unstructured":"Hagstrom E et al (2009) Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21):2765\u20132771","journal-title":"Circulation"},{"issue":"13","key":"9897_CR12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","volume":"31","author":"S Pilz","year":"2010","unstructured":"Pilz S, Tomaschitz A, Drechsler C et al (2010) Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 31(13):1591\u20131598 Epub 2010 May 2","journal-title":"Eur Heart J"},{"issue":"5","key":"9897_CR13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0272-6386(95)90541-3","volume":"25","author":"F Llach","year":"1995","unstructured":"Llach F (1995) Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited. Am J Kidney Dis 25(5):663\u2013679","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"9897_CR14","doi-asserted-by":"crossref","first-page":"c54","DOI":"10.1159\/000228076","volume":"113","author":"GT Schumock","year":"2009","unstructured":"Schumock GT et al (2009) Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients. Nephron Clin Pract 113(1):c54\u2013c61","journal-title":"Nephron Clin Pract"},{"key":"9897_CR15","doi-asserted-by":"crossref","unstructured":"Jassal SK, Chonchol M, M\u00fchlen DV et al (2010) Vitamin D, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med 123(12):1114\u20131120","DOI":"10.1016\/j.amjmed.2010.07.013"},{"key":"9897_CR16","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","volume":"16","author":"Y Slinin","year":"2005","unstructured":"Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16:1788\u20131793","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"9897_CR17","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/ndt\/gfn613","volume":"24","author":"A Covic","year":"2009","unstructured":"Covic A et al (2009) Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24(5):1506\u20131523","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"9897_CR18","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1210\/en.137.10.4285","volume":"137","author":"TB Usdin","year":"1996","unstructured":"Usdin TB et al (1996) Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology 137(10):4285\u20134297","journal-title":"Endocrinology"},{"issue":"1\u20133","key":"9897_CR19","first-page":"55","volume":"21","author":"M Smogorzewski","year":"1995","unstructured":"Smogorzewski M (1995) PTH, chronic renal failure and myocardium. Miner Electrolyte Metab 21(1\u20133):55\u201362","journal-title":"Miner Electrolyte Metab"},{"issue":"7","key":"9897_CR20","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/en.136.7.3024","volume":"136","author":"K Ogino","year":"1995","unstructured":"Ogino K, Burkhoff D, Bilezikian JP (1995) The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136(7):3024\u20133030","journal-title":"Endocrinology"},{"issue":"6 Pt 2","key":"9897_CR21","first-page":"H1739","volume":"263","author":"KD Schluter","year":"1992","unstructured":"Schluter KD, Piper HM (1992) Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 263(6 Pt 2):H1739\u2013H1746","journal-title":"Am J Physiol"},{"issue":"10","key":"9897_CR22","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","volume":"4","author":"K Amann","year":"1994","unstructured":"Amann K et al (1994) A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4(10):1814\u20131819","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"9897_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-2007-979898","volume":"27","author":"R Schleiffer","year":"1995","unstructured":"Schleiffer R, Pernot F, Jones R (1995) Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats. Horm Metab Res 27(1):16\u201318","journal-title":"Horm Metab Res"},{"issue":"5","key":"9897_CR24","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.HYP.30.5.1284","volume":"30","author":"M Noda","year":"1997","unstructured":"Noda M et al (1997) Increased expression of parathyroid hormone-related peptide gene in blood vessels of spontaneously hypertensive rats. Hypertension 30(5):1284\u20131288","journal-title":"Hypertension"},{"issue":"2","key":"9897_CR25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00365597909181172","volume":"13","author":"S Ejerblad","year":"1979","unstructured":"Ejerblad S, Eriksson I, Johansson H (1979) Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy. Scand J Urol Nephrol 13(2):161\u2013169","journal-title":"Scand J Urol Nephrol"},{"issue":"12","key":"9897_CR26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","volume":"71","author":"KR Neves","year":"2007","unstructured":"Neves KR et al (2007) Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int 71(12):1262\u20131270","journal-title":"Kidney Int"},{"issue":"4","key":"9897_CR27","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","volume":"292","author":"G Rashid","year":"2007","unstructured":"Rashid G et al (2007) Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 292(4):F1215\u2013F1218","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"9897_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000069761","volume":"26","author":"V Perkovic","year":"2003","unstructured":"Perkovic V et al (2003) Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res 26(1):27\u201333","journal-title":"Kidney Blood Press Res"},{"issue":"22","key":"9897_CR29","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","volume":"24","author":"FN Saleh","year":"2003","unstructured":"Saleh FN et al (2003) Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24(22):2054\u20132060","journal-title":"Eur Heart J"},{"issue":"2","key":"9897_CR30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000184887","volume":"48","author":"JD Harnett","year":"1988","unstructured":"Harnett JD et al (1988) Left ventricular hypertrophy in end-stage renal disease. Nephron 48(2):107\u2013115","journal-title":"Nephron"},{"issue":"3","key":"9897_CR31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.1999.00651.x","volume":"50","author":"A Piovesan","year":"1999","unstructured":"Piovesan A et al (1999) Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50(3):321\u2013328","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1\u20133","key":"9897_CR32","first-page":"72","volume":"21","author":"S Hara","year":"1995","unstructured":"Hara S et al (1995) Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients. Miner Electrolyte Metab 21(1\u20133):72\u201376","journal-title":"Miner Electrolyte Metab"},{"issue":"1","key":"9897_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0272-6386(99)70260-X","volume":"33","author":"CW Park","year":"1999","unstructured":"Park CW et al (1999) Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 33(1):73\u201381","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"9897_CR34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI111765","volume":"75","author":"M Akmal","year":"1985","unstructured":"Akmal M et al (1985) Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75(3):1037\u20131044","journal-title":"J Clin Invest"},{"issue":"1","key":"9897_CR35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI114979","volume":"87","author":"GZ Fadda","year":"1991","unstructured":"Fadda GZ et al (1991) On the mechanism of impaired insulin secretion in chronic renal failure. J Clin Invest 87(1):255\u2013261","journal-title":"J Clin Invest"},{"issue":"5","key":"9897_CR36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2265.2005.02363.x","volume":"63","author":"CG Ogard","year":"2005","unstructured":"Ogard CG et al (2005) Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 63(5):493\u2013498","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"9897_CR37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","volume":"56","author":"E Delfini","year":"2007","unstructured":"Delfini E et al (2007) Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 56(1):30\u201336","journal-title":"Metabolism"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9897-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-010-9897-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-010-9897-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T23:44:57Z","timestamp":1637279097000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-010-9897-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9897"],"URL":"https:\/\/doi.org\/10.1007\/s11255-010-9897-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}